NCT04271709Active, not recruiting
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
The Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
Source: ClinicalTrials.gov · Last updated 16 Oct 2026
Brief summary (registry, in English)
The investigators are conducting a 5-year prospective, 2:1 cluster-randomized controlled trial, funded by the Centers for Disease Control (CDC), which provides vision screenings to underserved New York City residents living in affordable housing buildings in Harlem and Washington Heights.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 749 (actual)
- First submitted
- 13 Feb 2020
- Start date
- 30 Sept 2019
- Primary completion date
- 29 Sept 2029
- Lead sponsor
- Columbia University
- Diseases
- Glaucoma, Diabetic eye disease
- NCT number
- NCT04271709
What you commit to
- Study type: Interventional
- Participants enrolled: 749
- From 30 Sept 2019 to the primary completion date, 29 Sept 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Self-reported terminal illness with life expectancy less than 1 year
- Inability to provide informed consent due to dementia or other reasons
Who the study is looking for
- Individuals over age 40
- Living independently in NYCHA housing building or attending DFTA Senior Center
- Willing to answer COVID-19 symptom questions
- Willing to consent for 2 vision screening visits at baseline and 12-month follow-up
Age in the registry: 40 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Columbia University Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.